SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Celldex Therapeutics, Inc. & Its Board of Directors in...
March 07 2016 - 3:15PM
Business Wire
Levi & Korsinsky announces it has commenced an investigation
of Celldex Therapeutics, Inc. (NASDAQ: CLDX) concerning possible
violations of federal securities laws by the Company and/or certain
of its officers and directors.
On March 7, 2016, Celldex stock fell more than 50% on intraday
trading following the Company’s disclosure that it will discontinue
its late-stage study of RINTEGA. In a Company press release,
Celldex noted that an independent Data Safety and Monitoring Board
found that the trial will likely “not reach statistical significant
for overall survival in patients with minimal residual disease, the
primary end-point of the study.” To obtain additional information
about this investigation, go to:
http://zlk.9nl.com/celldex-therapeutics-cldx
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, California, Connecticut and Washington D.C. The
firm’s attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities lawsuits and have recovered
hundreds of millions of dollars for aggrieved shareholders. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160307006444/en/
Levi & Korsinsky, LLPEduard Korsinsky, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2023 to Apr 2024